(Canada) Analysis - DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: Ethical Issues (eg. equity?) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, September 16, 2016

(Canada) Analysis - DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: Ethical Issues (eg. equity?)



 Blogger's Note: a second book (analysis of issues)

open access - NCBI Bookshelf

Show details
CADTH Optimal Use Report, No. 5.3c.
Duthie K, Bond K, Kaunelis D.
 Distributing the benefits and burdens fairly (equity)
Another consideration for the implementation of universal dMMR tumour testing for both treatment optimization and LS diagnosis is whether access to the necessary expertise and services is fairly distributed among the affected population regardless of income level, education, or cultural background. If it is found that the current system favours access only for those of a particular group (especially a privileged group) and that this injustice cannot be rectified, decision-makers would need to think carefully about implementing such a program.

1 comment :

  1. Scrap the potential program due to injustices or make the injustices right!

    ReplyDelete

Your comments?

1 comment :

  1. Scrap the potential program due to injustices or make the injustices right!

    ReplyDelete

Your comments?